Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Ebiomedicine|September 19, 2021
Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasisYang Liu, Hai-Wen Lu, Shu-Yi Gu, et al.
The Clinical Respiratory Journal|November 24, 2019
The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasisHai-Wen Lu, Bei Mao, Ping Wei, et al.
ACS Biomaterials Science & Engineering|May 10, 2021
Albumin-Based LL37 Peptide Nanoparticles as a Sustained Release System against Pseudomonas aeruginosa Lung InfectionLing Yang, Yang Liu, Ning Wang, et al.
Cellular & Molecular Immunology|May 22, 2023
Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammationSongling Zhu, Shufen Zhong, Kebin Cheng, et al.
Nature Communications|December 26, 2025
Evidence for Interleukin-17C governing interleukin-17A pathogenicity and promoting asthma endotype switching in bronchiectasisYu-Wei Zhang, Yu-Hua Wen, Ling Yang, et al.
The Clinical Respiratory Journal|July 31, 2017
Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical AssociationBin Cao, Yi Huang, Dan-Yang She, et al.
Nature Immunology|May 20, 2018
CARD9S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responsesXia Xu, Jin-Fu Xu, Guoxing Zheng, et al.
EMBO Molecular Medicine|November 30, 2019
Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infectionYue-Qing Zhou, Yun Shi, Ling Yang, et al.
Frontiers in Cellular and Infection Microbiology|October 29, 2020
Candida in Lower Respiratory Tract Increases the Frequency of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Case-Control StudyYi-Hui Zuo, Wei-Qin Wang, Qi-Jian Chen, et al.
BMJ Open Respiratory Research|July 20, 2026
Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbationsHenrik Watz, Frank C Sciurba, Matteo Bonini, et al.
Pageof 14